Alpha‑2C Adrenergic Receptor Market – Targeting CNS and Cardiovascular Indications with Precision
The alpha‑2C adrenergic receptor market focuses on therapies and research tools targeting this G‑protein coupled receptor, implicated in neurotransmission, cardiovascular regulation, and psychiatric conditions. Modulating ADRA2C is being explored for hypertension, anxiety, depression, pain, and emerging oncology applications. The market was valued at around USD 799.2 million in 2024, about USD...
0 Commenti 0 condivisioni 19 Views 0 Anteprima